Yosuf El-Shabrawi

Dr. Yosuf El-Shabrawi

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2017 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
SSStephanie Sarny
Stephanie Sarny
MNMichael Neumayer
Michael Neumayer
JKJulian Kofler
Julian Kofler
YEYosuf El-Shabrawi
Yosuf El-Shabrawi
To report a case of uveitis and neuroretinal detachment in a patient treated with Trametinib and Dabrafenib due to metastatic cutaneous melanoma stage IV. We evaluated slit lamp examination, fundoscopy, optical coherence tomography, fluorescein and indocyanine green angiography in a 66 years old man suffering visual loss. Fundoscopy showed serous neuroretinal detachment of the fovea accompanied with white spots surrounding the fovea in both eyes. Although therapy with Trametinib and Dabrafenib was stopped uveitis anterior was seen 2 weeks later. After a year, the therapy was started again and the serous neuroretinal detachment appeared once more, however without inflammatory reaction of the anterior chamber. Patients treated with Trametinib and Dabrafenib should undergo consecutive eye examinations from the beginning of the therapy.

23 January 2009 in Eye
Verified
Journal Article
Open access
PDF file
KWK Weiss
K Weiss
ISI Steinbrugger
I Steinbrugger
MWM Weger
M Weger
NAN Ardjomand
N Ardjomand
RMR Maier
R Maier
YEYosuf El-Shabrawi
Yosuf El-Shabrawi
Clinical data suggest a role for VEGF in uveitic cystoid macular oedema (CME), even though the data on intravitreal VEGF levels in these eyes is still inconclusive. We determined intravitreal VEGF levels and treated uveitis patients with intravitreal bevacizumab. Intravitreal VEGF levels were measured in eight uveitis patients and 10 controls using cytometric bead array technology. In 11 eyes of a second group of uveitis patients, CME was treated using 1.25 mg bevacizumab intravitreally. Re-injections of bevacizumab were given in patients showing a transient positive effect, defined as an increase of the best-corrected vision of at least two lines on a snellen chart. Alternatively, triamcinolone was given in patients, not responding to bevacizumab. Mean intravitreal VEGF concentration was 82.75±171.71 pg/ml (±SD) (range, 0.0–502.1 pg/ml), and below the detection levels in controls. A significant reduction of retinal thickness was seen at weeks 2 (P=0.001) and 4 (P=0.007). A significant improvement in VA was seen at week 2 (P=0.02). Patients presenting with a CME in baseline fluorescein-angiogram responded well towards bevacizumab treatment, unless an extensive leakage from the choroid or a leakage of the optic disk was detectable. In these patients, only intravitreally administered triamcinolone led to a reduction of the CME. Our data suggest that patients presenting with a diffuse leakage from the choroid in the fluorescein angiogram or an extensive leakage of the optic disk should be treated with intravitreal triamcinolone, whereas in patients presenting only a cystoid macular oedema bevacizumab treatment seems like a good choice.

1 April 2006 in Ophthalmology
Verified
Journal Article
Closed access
YEYosuf El-Shabrawi
Yosuf El-Shabrawi
BWBeate J. Wegscheider
Beate J. Wegscheider
MWMartin Weger
Martin Weger
WRWilfried Renner
Wilfried Renner
UPUrsula Posch
Ursula Posch
JHJosef Hermann
Josef Hermann

1 October 1994 in Hepatology
Verified
Journal Article
Open access
PDF file
LKLukas Kenner
Lukas Kenner
YEYosuf El-Shabrawi
Yosuf El-Shabrawi
HHHeinz Hutter
Heinz Hutter
MFMichael Forstner
Michael Forstner
Kurt ZatloukalKurt Zatloukal
Kurt Zatloukal
HDHelmut Denk
Helmut Denk
Tau protein is a member of the family of microtubule–associated proteins, which support microtubule polymerization and stability. Under pathological conditions, tau is a major constituent of neurofibrillary tangles in nerve cells of patients with Alzheimer's disease. Neurofibrillary tangles share some morphological, biochemical and immunological properties with cytoplasmic inclusions associated with other diseases, such as Mallory bodies in the livers of patients with alcoholic hepatitis and in corresponding mouse models. Recently a Mallory body component was identified that in molecular mass and isoelectric point resembles the abnormally phosphorylated tau of neurofibrillary tangles. There has been, however, so far no report describing the occurrence of tau in normal liver. We now demonstrate the expression of two tau isoforms containing three and four repeats, respectively, of the microtubule–binding domains in normal mouse liver and kidney. This finding provides evidence for a physiological role of tau in the liver and, consequently, the basis for the involvement of tau in pathological situations. (Hepatology 1994;20:1086-1089).

1 October 2011 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
ELEwald Lindner
Ewald Lindner
MWMartin Weger
Martin Weger
GSGernot Steinwender
Gernot Steinwender
AGAntonia Griesbacher
Antonia Griesbacher
UPUrsula Posch
Ursula Posch
YEYosuf El-Shabrawi
Yosuf El-Shabrawi
Purpose.: Uveitis is a major cause for visual impairment. Inflammation-related gene polymorphisms have previously been shown to confer susceptibility to different types of uveitis. Recently, IL-2 receptor alpha (IL2RA, also called CD25) and IL-7 receptor alpha (IL7RA) gene variants (rs2104286, rs12722489, and rs6897932) have been identified to play an essential role in the pathogenesis of immune-mediated diseases. Their role in uveitis, however, has not yet been studied. The present study was set to investigate a hypothesized association of these gene polymorphisms and the presence of either intermediate or HLA-B27–associated acute anterior uveitis. Methods.: One hundred forty-five patients with HLA-B27–associated acute anterior uveitis (AAU), 84 patients with intermediate uveitis, 132 HLA-B27–negative controls, and 61 HLA-B27–positive controls were enrolled. Determination of genotypes was done by polymerase chain reaction. Results.: The frequency of carriers of the minor allele for rs2104286 was significantly lower in patients with intermediate uveitis compared with HLA-B27 positive and negative controls combined (P = 0.006). Frequencies of the minor allele for rs2104286 did not differ significantly in patients with HLA-B27–associated uveitis (28.3%) when compared with HLA-B27–negative controls (24.2%; P = 0.29) and HLA-B27–positive controls (30.3%; P = 0.72). The rs12722489 and rs6897932 polymorphisms were not significantly associated with either investigated uveitis entity (P > 0.005). Conclusions.: These findings suggest an association of the rs2104286 polymorphism with intermediate uveitis, but not with HLA-B27–associated acute anterior uveitis. Because this polymorphism was associated with multiple sclerosis in previous studies, the authors suggest possible parallel pathways between multiple sclerosis and intermediate uveitis but not HLA-B27–associated uveitis.

1 October 1998 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
CLCharalampos Livir-Rallatos
Charalampos Livir-Rallatos
YEYosuf El-Shabrawi
Yosuf El-Shabrawi
PZPanayotis Zatirakis
Panayotis Zatirakis
PPPhilip E. Pellett
Philip E. Pellett
FSFelicia R. Stamey
Felicia R. Stamey
CFC.STephen Foster
C.STephen Foster